Harvoni Tablets

on the pharmaceutical market in november 2014 for the first time appeared a highly effective innovative drug of the new generation “harvoni tablets price in india” from the american company gilead sciences, the application of which is approved in the us and eu countries. The drug effectively treats hepatitis c of both the first and fourth hcv genotypes. Therapy with harvoni is the first fda-approved treatment regimen that does not involve the simultaneous combination of the drug with interferon-alpha and greatly simplifies the choice of course of therapy.

• hepatitis c is a very serious disease with irreversible disorders: liver cirrhosis, hepatic insufficiency, hepatocellular carcinoma (hcc, liver cancer), abdominal infections, oncological problems. Since the introduction of this newest antiviral medication,
• it has become much easier to prevent the development of the above-listed severe conditions and diseases, and the number of unpleasant consequences in patients is significantly reduced.